General Information of Drug (ID: DMHP4AX)

Drug Name
BMS-986242
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
PubChem CID
121318866
TTD ID
D0XJ9U

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)